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Propranolol-resistant infantile haemangiomas
Caussé et al. performed a retrospective, observational, multi-
centre study from February 2011 to December 2011 to assess 
the characteristics of propranolol-resistant infantile haemangio-
mas (PRIH). Among 1130 patients treated with propranolol for 
infantile haemangioma, 10 (0.9%) had PRIHs. Resistance was 
observed at all ages during early childhood and at any prolif-
eration stage. It is concluded PRIH is a rare phenomenon that 
raises questions and merits further investigation. Br J Dermatol 
2013; 169: 125–29.
In vivo confocal microscopy and nodular lesions
The aim of this retrospective study was to define the role of 
reflectance confocal microscopy (RCM) in diagnosing nodular 
lesions in clinical practice. The study consisted of 140 nodular 
lesions (23 ‘pure’ nodular melanomas, nine melanoma metas-
tases, 28 basal cell carcinomas, six invasive squamous cell 
carcinomas, 32 naevi, 14 seborrhoeic keratoses, 17 dermato-
fibromas, five vascular lesions and six other lesions). RCM 
correctly diagnosed 121 of 140 lesions (86.4%). Eight lesions 
revealed discordance between histopathology and confocal 
microscopy, eight cases were not evaluable by means of RCM 
due to the presence of ulceration or hyperkeratosis and three 
cases showed a nonspecific pattern. Confocal microscopy 
reached a 96.5% sensitivity and 94.1% specificity for the diag-
nosis of melanoma. It is concluded that RCM is an effective 
instrument in diagnosing nodular lesions; further prospective 
studies on difficult-to-diagnose nodules are recommended. 
Br J Dermatol 2013; 169: 58–67.
EB and α6β4 integrin mutations
In this study, a broad spectrum of clinical and morphological 
epidermolysis bullosa (EB) manifestations associated with 10 
novel α6β4 integrin mutations is presented. Of the 10 novel 
mutations, one was in ITGA6 and nine in ITGB4. Skin cleav-
age was either intraepidermal or junctional. Lethal outcome 
and pyloric atresia (PA) correlated with loss of function muta-
tions in two cases. Solely mild skin involvement was associated 
with deletion of the C-terminus of β4 integrin. Combinations 
of missense, nonsense or frameshift mutations caused severe 
urinary tract involvement in addition to skin fragility in five 
cases. In four out of six cases of EB-PA, life expectancy was not 
impaired. Br J Dermatol 2013; 169: 115–124.
Etanercept and narrowband UVB phototherapy
Calzavara-Pinton et al. report the treatment results of a 
group of 322 consecutive patients with psoriasis who were 
treated with narrowband ultraviolet B (NB-UVB). Twenty 
patients who were unresponsive to NB-UVB were ineligible 
or unresponsive to subsequent conventional systemic 
therapies and were treated with etanercept (ETN). Eight 
patients were unresponsive to both ETN and NB-UVB and 
the combination therapy of ETN plus NB-UVB was needed. 
All eight patients achieved PASI 75. All patients relapsed, 
with PASI > 10 within 2.8 ± 1.7 months. It is concluded that 
the combined treatment has a synergistic effect for clear-
ing psoriasis previously unresponsive to ETN and NB-UVB 
photo therapy alone. The clearance rate is high in a short 
time without short-term adverse effects. However, concerns 
regarding potential longer term carcinogenicity remain. Br J 
Dermatol 2013; 169: 130–36.Journal of Investigative Dermatology (2013) 133, 1916. doi:10.1038/jid.2013.246
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